Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Disturbances in iron homeostasis result in accelerated rejection after experimental heart transplantation.

Resch T, Ashraf MI, Ritschl PV, Ebner S, Fabritius C, Brunner A, Schäfer G, Regele H, Günther J, Weiss G, Kotsch K.

J Heart Lung Transplant. 2017 Jul;36(7):732-743. doi: 10.1016/j.healun.2017.03.004. Epub 2017 Mar 7.

PMID:
28372951
2.

Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.

Fabritius C, Ritschl PV, Resch T, Roth M, Ebner S, Günther J, Mellitzer V, Nguyen AV, Pratschke J, Sauter M, Klingel K, Kotsch K.

Am J Transplant. 2017 Dec;17(12):3199-3209. doi: 10.1111/ajt.14467. Epub 2017 Sep 9.

3.

Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.

Chun N, Fairchild RL, Li Y, Liu J, Zhang M, Baldwin WM 3rd, Heeger PS.

Am J Transplant. 2017 Nov;17(11):2810-2819. doi: 10.1111/ajt.14328. Epub 2017 May 30.

PMID:
28444847
5.

Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.

Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, Ichim TE, Zhou D, Lian D, Kelvin DJ, Zhong R.

J Immunol. 2003 Oct 1;171(7):3823-36.

6.

Tanshinol suppresses cardiac allograft rejection in a murine model.

Lu C, Zeng YQ, Liu H, Xie Q, Xu S, Tu K, Dou C, Dai Z.

J Heart Lung Transplant. 2017 Feb;36(2):227-236. doi: 10.1016/j.healun.2016.07.016. Epub 2016 Jul 27.

PMID:
27574736
7.

Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.

El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL.

Circulation. 2005 Jul 19;112(3):320-31. Epub 2005 Jul 5.

PMID:
15998678
8.

Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Shimizu K, Libby P, Rocha VZ, Folco EJ, Shubiki R, Grabie N, Jang S, Lichtman AH, Shimizu A, Hogg N, Simon DI, Mitchell RN, Croce K.

Circulation. 2011 Dec 20;124(25):2920-32. doi: 10.1161/CIRCULATIONAHA.110.009910. Epub 2011 Dec 5.

9.

NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.

van der Touw W, Burrell B, Lal G, Bromberg JS.

Transplantation. 2012 Sep 27;94(6):575-84.

10.

Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.

Gong W, Huang T, Ge F, Luo G, Yuan S, Gao D, Kong D.

Transplantation. 2013 Oct 15;96(7):609-15. doi: 10.1097/TP.0b013e31829df26d.

PMID:
23880577
11.

Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.

Kimura N, Itoh S, Nakae S, Axtell RC, Velotta JB, Bos EJ, Merk DR, Gong Y, Okamura H, Nagamine CM, Adachi H, Kornfeld H, Robbins RC, Fischbein MP.

J Heart Lung Transplant. 2011 Dec;30(12):1409-17. doi: 10.1016/j.healun.2011.08.017.

PMID:
22055099
12.

Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.

Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, Fairchild RL.

J Immunol. 2001 Sep 1;167(5):2979-84.

13.

T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts.

Kondo T, Watarai Y, Novick AC, Toma H, Fairchild RL.

Transplantation. 1997 Mar 15;63(5):732-42.

PMID:
9075847
15.

Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.

Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, Thomson AW.

Transplantation. 1997 Dec 27;64(12):1808-15.

PMID:
9422424
16.

Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.

Zhang A, Wang K, Zhou C, Gan Z, Ma D, Ye P, Sun Y, Wu J, Huang X, Ren L, Deng P, Wu C, Yue Z, Ding X, Chen J, Xia J.

J Heart Lung Transplant. 2017 Feb;36(2):175-184. doi: 10.1016/j.healun.2016.04.018. Epub 2016 May 6.

PMID:
27296836
17.

Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.

Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu W, Mele T, Garcia B, Wang H.

Transplantation. 2008 Aug 15;86(3):460-8. doi: 10.1097/TP.0b013e3181806b72.

PMID:
18698251
18.

5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.

Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, Abe F, Nakajima M, Tanaka T, Xu J, Zou H, Ding Q, Li XK.

J Heart Lung Transplant. 2015 Feb;34(2):254-63. doi: 10.1016/j.healun.2014.09.037. Epub 2014 Oct 2.

PMID:
25455753
19.

Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.

Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML.

J Immunol. 2000 Nov 15;165(10):5580-7.

20.

Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.

Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR.

Circulation. 2009 Nov 3;120(18):1814-21. doi: 10.1161/CIRCULATIONAHA.108.840223. Epub 2009 Oct 19.

PMID:
19841304

Supplemental Content

Support Center